Clinical Trial Update: Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a three-drug antiemetic regimen (fosaprepitant dimeglumine, palonosetron hydrochloride, and dexamethasone) for preventing cisplatin-ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Palonosetron hydrochloride (Palonosetron hydrochloride)
• fosaprepitant dimeglumine (fosaprepitant dimeglumine)

Snippet

Sponsor: University of Washington | Conditions: Nausea and Vomiting, Stage III Squamous Cell Carcinoma of the Hypopharynx | Phase 2 | Status: TERMINATED | Results posted: 2017-05-18